Exploratory study characterizes microstructural changes in hepatic encephalopathy, suggesting potential monitoring tools.
Background Hepatic encephalopathy (HE) involves complex neurobiological changes that are often difficult to quantify using conventional MRI. This study aims to utilize Neurite Orientation Dispersion and Density Imaging (NODDI) combined with Gray-matter Based Spatial Statistics (GBSS) to characterize microstructural alterations in patients with HE and explore their relationship with clinical biochemical markers, specifically within the globus pallidus (GP). Methods Thirty-three patients with HE and 31 healthy controls underwent 3 T MRI including a multi-shell diffusion protocol for NODDI. GBSS was performed to assess differences in the Neurite Density Index (NDI) and Orientation Dispersion Index (ODI). Pearson correlation analyzed relationships between GP NODDI parameters and blood biochemical indices. Results HE patients exhibited significantly decreased NDI across widespread cortical and sub-cortical regions (frontal, parietal, temporal, cingulate, insula, thalamus) and increased ODI in the posterior cerebellum/vermis. Exploratory ROI analysis of the globus pallidus (GP)—a region known for manganese deposition but showing no significant group-level differences in this study- revealed that, the NDI of the right GP showed positive correlations with indirect bilirubin and prothrombin international normalized ratio (all uncorrected p < 0.05), while the ODI of the left GP positively correlated with hemoglobin concentration (uncorrected p = 0.046). Conclusion NODDI reveals extensive microstructural alterations consistent with reduced neurite density index and cerebellar disorganization in HE. The dissociated correlation patterns of GP NDI and ODI with distinct blood markers may be compatible with a hypothetical “double-hit” pathophysiological model: toxic metabolite accumulation may drive cellular swelling (increased NDI), while systemic factors like anemia may reduce structural complexity (decreased ODI). However, these exploratory associations do not allow causal inference. These findings highlight NODDI could be a useful tool for monitoring the progression and metabolic impact of HE.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: